$15.49
-0.20-1.27%
At close: -
$15.51
0.020.14%
After Hours: 4:39 PM EDT
Comments
Loading...
Teva Pharmaceutical Indus Earnings Estimates, EPS & Revenue | NYSE:TEVA | Benzinga
Teva Pharmaceutical Indus reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$0.550
Quarterly Revenue Estimate
$3.86B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$16.54B
Analyze the earnings history of Teva Pharmaceutical Indus using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Indus | $0.48 | $0.55 | — | — | $3.82B | $3.86B | — | — | 05/07/2025 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $1.00 | $0.70 | $0.71 | 1.43% | $4.46B | $4.12B | $4.23B | 2.65% | 01/29/2025 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.60 | $0.66 | $0.69 | 4.55% | $3.85B | $4.12B | $4.33B | 5.15% | 11/06/2024 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.56 | $0.55 | $0.61 | 10.91% | $3.88B | $4.06B | $4.16B | 2.56% | 07/31/2024 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.40 | $0.51 | $0.48 | -5.88% | $3.66B | $3.73B | $3.82B | 2.39% | 05/08/2024 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.71 | $0.77 | $1.00 | 29.87% | $3.88B | $4.01B | $4.46B | 11.15% | 01/31/2024 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.59 | $0.61 | $0.60 | -1.64% | $3.60B | $3.72B | $3.85B | 3.49% | 11/08/2023 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.68 | $0.52 | $0.56 | 7.69% | $3.79B | $3.71B | $3.88B | 4.53% | 08/02/2023 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.55 | $0.56 | $0.40 | -28.57% | $3.66B | $3.63B | $3.66B | 0.85% | 05/10/2023 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.77 | $0.71 | $0.71 | 0.00% | $4.10B | $3.93B | $3.88B | -1.17% | 02/08/2023 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.59 | $0.62 | $0.59 | -4.84% | $3.89B | $3.83B | $3.60B | -6.14% | 11/03/2022 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.59 | $0.57 | $0.68 | 19.30% | $3.91B | $3.78B | $3.79B | 0.16% | 07/26/2022 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.63 | $0.55 | $0.55 | 0.00% | $3.98B | $3.75B | $3.66B | -2.37% | 05/03/2022 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.68 | $0.73 | $0.77 | 5.48% | $4.45B | $4.29B | $4.10B | -4.43% | 02/09/2022 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.58 | $0.65 | $0.59 | -9.23% | $3.98B | $4.03B | $3.89B | -3.55% | 10/27/2021 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.55 | $0.59 | $0.59 | 0.00% | $3.87B | $4.04B | $3.91B | -3.22% | 07/28/2021 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.76 | $0.59 | $0.63 | 6.78% | $4.36B | $4.02B | $3.98B | -0.95% | 04/28/2021 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.62 | $0.63 | $0.68 | 7.94% | $4.47B | $4.37B | $4.45B | 1.92% | 02/10/2021 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.58 | $0.58 | $0.58 | 0.00% | $4.26B | $4.07B | $3.98B | -2.26% | 11/05/2020 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.60 | $0.53 | $0.55 | 3.77% | $4.34B | $3.93B | $3.87B | -1.53% | 08/05/2020 | Get Alert |
| TEVA | Teva Pharmaceutical Indus | $0.60 | $0.59 | $0.76 | 28.81% | $4.29B | $4.15B | $4.36B | 4.99% | 05/07/2020 | Get Alert |
Teva Pharmaceutical Indus (TEVA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-01-29 | $0.71 | $0.70 | 1.43 % |
| Q3 | 2024-11-06 | $0.69 | $0.66 | 4.55 % |
| Q2 | 2024-07-31 | $0.61 | $0.55 | 10.9 % |
| Q1 | 2024-05-08 | $0.48 | $0.51 | -5.88 % |
Teva Pharmaceutical Indus (TEVA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-01-29 | $4.23B | $4.12B | 2.65 % |
| Q3 | 2024-11-06 | $4.33B | $4.12B | 5.15 % |
| Q2 | 2024-07-31 | $4.16B | $4.06B | 2.56 % |
| Q1 | 2024-05-08 | $3.82B | $3.73B | 2.39 % |
FAQ
When is Teva Pharmaceutical Indus (NYSE:TEVA) reporting earnings?
Teva Pharmaceutical Indus (TEVA) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on January 29, 2025 for Q4.
What were the latest earnings per share (EPS) for Teva Pharmaceutical Indus (NYSE:TEVA)?
The Actual EPS was $0.71, which beat the estimate of $0.70.
What were Teva Pharmaceutical Indus’s (NYSE:TEVA) revenues?
The Actual Revenue was $4.2B, which beat the estimate of $4.1B.
Browse earnings estimates, EPS, and revenue on all stocks.